Decades of research have generated knowledge and tools that, in theory, could prevent all new HIV infections and ultimately eliminate AIDS. Reality falls far short, in part due to major pressing unmet needs, many of which fall within two domains: Continuum of Care (assuring that all HIV-infected individuals are diagnosed, connected to care, and maintained in care); and Personalized HIV Care (assuring optimally safe and effective therapy based on understanding determinants of inter-individual variability). The proposed Tennessee Center for AIDS Research (TN-CFAR) is located in the Southeastern US, the region with the greatest number of new HIV infections, and of persons living with HIV. Under the leadership of Prof. Simon Mallal (recruited to Vanderbilt to lead this Center) we have forged a unique partnership between a research- intensive institution (Vanderbilt University, VU), an academic health sciences center focused on minority and underserved populations (Meharry Medical College, MMC), and an academically engaged state health department (Tennessee Department of Health, TDH). Our vision is to have transformative, local and global translational impact. Guided by this vision, our mission is to coordinate institutional and community resources and focus efforts on high-priority targets to most effectively reduce the burden of HIV/AIDS and generalize these benefits nationally and globally. We will leverage complementary strengths of VU, MMC, and TDH to focus research efforts on unmet needs. This strategy we will also most effectively serve the traditional CFAR roles of institutional leadership, core service, and fosterig career development of junior investigators. We will focus on four specific aims: 1) To foster collaborations between VU, MMC, and TDH that focus resources and research to improve the continuum of care in Tennessee and beyond; 2) To coordinate research into determinants of interindividual variability in response to HIV interventions so as to improve personalized HIV care, outcomes, and resource utilization; 3) To create and act upon new opportunities for HIV clinical/translational research at MMC, and between MMC and VU; and 4) To develop and grow a new emphasis on HIV-focused community engaged research that will pervade this CFAR.

Public Health Relevance

Overall - NARRATIVE The Tennessee CFAR (TN-CFAR) is an HIV/AIDS research collaboration between Vanderbilt University, Meharry Medical College, and the Tennessee State Department of Health. The TN- CFAR aims to enhance HIV/AIDS-related research by coordinating institutional and community resources, with the goal of reducing the burden of HIV/AIDS in our state and generalizing these benefits nationally and internationally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
6P30AI110527-02
Application #
9040954
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
2015-04-01
Project End
2020-03-31
Budget Start
2016-05-01
Budget End
2017-03-31
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Koethe, John R; Jenkins, Cathy A; Furch, Briana D et al. (2018) Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr 79:135-140
Phillips, Elizabeth J; Mallal, Simon A (2018) Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration. J Clin Invest 128:2746-2749
Rebeiro, Peter F; Howe, Chanelle J; Rogers, William B et al. (2018) The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States. AIDS Care 30:1426-1434
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Balasubramaniam, Muthukumar; Zhou, Jing; Addai, Amma et al. (2018) PF74 Inhibits HIV-1 Integration by Altering The Composition of the Preintegration Complex. J Virol :
Tan, Yi; Tsan-Yuk Lam, Tommy; Heberlein-Larson, Lea A et al. (2018) Large scale complete genome sequencing and phylodynamic analysis of eastern equine encephalitis virus reveal source-sink transmission dynamics in the United States. J Virol :
Rickles, Michael; Rebeiro, Peter F; Sizemore, Lindsey et al. (2018) Tennessee's In-state Vulnerability Assessment for a ""Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection"" Event Utilizing Data About the Opioid Epidemic. Clin Infect Dis 66:1722-1732
Koethe, John R; McDonnell, Wyatt; Kennedy, Arion et al. (2018) Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons. J Acquir Immune Defic Syndr 77:e14-e21
Stone Jr, Cosby A; Liu, Yiwei; Relling, Mary V et al. (2018) Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract :
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459

Showing the most recent 10 out of 126 publications